Add BrightSurf on Google Email

The Mount Sinai Hospital / Mount Sinai School of Medicine


Researchers gain better understanding of mechanism behind tau spreading in the brain

A research group led by Giulio Maria Pasinetti has discovered that misfolded tau released by neurons can spread to surrounding cells, promoting the progression of neurodegenerative disorders. A grape-seed extract enriched in polyphenols was also found to prevent cell-to-cell spread of tau pathology.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of Biological Chemistry·DateMay 1, 2012

Swallowing exercises can help patients with head and neck cancer

A study published in Archives of Otolaryngology – Head & Neck Surgery suggests that targeted swallowing exercises can alleviate debilitating side effects in people undergoing chemoradiation therapy for head and neck cancer. Patients who performed five targeted swallowing exercises throughout their CRT showed significantly better scores...

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalArchives of Otolaryngology - Head and Neck Surgery·DateApr 19, 2012

New 'genetic bar code' technique establishes ability to derive DNA information from RNA

Researchers developed a method to derive DNA information from RNA, allowing for identification of individuals in massive research repositories. This technique raises questions about DNA and RNA data bank privacy issues, and may enable tracking of individual characteristics like age, sex, and disease risks.

Mount Sinai releases landmark research at American College of Cardiology meeting

Researchers from Mount Sinai School of Medicine presented several studies at the American College of Cardiology's annual scientific session. One study found that aggressive statin therapy reduced fat content in coronary blockage by 22 percent, while another showed that cardiovascular disease screening can identify risk factors and symp...

Young adults allowed to stay on parents' health insurance have improved access to care

Researchers found laws permitting young adults to stay on their parents' health insurance until age 26 result in improved access to healthcare. The study analyzed data from the U.S. Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System survey, comparing periods before and after state laws were enacted.

Decaffeinated coffee preserves memory function by improving brain energy metabolism

Researchers found that decaffeinated coffee improves glucose utilization in the brain, reducing the risk of neurocognitive problems associated with type 2 diabetes. The study suggests that decaffeinated coffee may have preventive benefits for cognitive decline caused by aging and neurodegenerative disorders.

Exposure to chemical found in personal care products may contribute to childhood obesity

Researchers at The Mount Sinai Hospital found an association between phthalate exposure and increased body mass index (BMI) and waist circumference in young children. Greater than 97% of study participants had been exposed to phthalates, which are man-made chemicals that mimic the body's natural hormones.

Researchers discover clues to developing more effective antipsychotic drugs

Researchers from Mount Sinai School of Medicine identified the pattern of cell signaling induced by antipsychotic drugs in a complex composed of two brain receptors linked to schizophrenia. This discovery may allow for the prediction of novel compounds' effectiveness and accelerate the development of better antipsychotic drugs.

Pituitary hormone TSH found to directly influence bone growth

A new study from Mount Sinai School of Medicine reveals that thyroid-stimulating hormone (TSH) directly influences bone growth, contrary to its usual thyroid functions. The findings suggest TSH may be a novel method for addressing bone production and could lead to innovative treatments for osteoporosis.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalProceedings of the National Academy of Sciences·DateSep 13, 2011

Unique study shows efficacy of imaging technology in evaluating heart drug dalcetrapib

Researchers used MRI and PET/CT to prove the efficacy of dalcetrapib in preventing atherosclerosis progression and reducing vascular inflammation over 24 months. The study found significant reductions in atherosclerotic disease progression and arterial inflammation, suggesting a promising new treatment for cardiovascular disease.

Foods with baked milk may help build tolerance in children with dairy allergies

A recent study conducted at Mount Sinai School of Medicine found that introducing baked milk products into the diets of children with milk allergies accelerated the rate at which they outgrew their allergy. After five years, 47% of children in the experimental group could tolerate unheated milk products, compared to 22% in a control gr...

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of Allergy and Clinical Immunology·DateJul 1, 2011

New research suggests dramatic shift in understanding of personalized medicine

A recent study published in PLOS ONE found that ancestral genetic heritage is not fixed at the individual level for African-American and Hispanic patients, but rather varies widely within each group. This research challenges traditional ethnic labels and highlights the importance of considering individual genotypes in personalized medi...

Low carbohydrate diet may reverse kidney failure in people with diabetes

Researchers from Mount Sinai School of Medicine have found that a ketogenic diet may reverse impaired kidney function in people with Type 1 and Type 2 diabetes. The study, published in PLoS ONE, also identified previously unreported genes associated with diabetes-related kidney failure whose expression was reversed by the diet.

Indications of Alzheimer's disease may be evident decades before first signs of cognitive impairment

Researchers at Mount Sinai School of Medicine found that patients with Alzheimer's disease have lower glucose utilization in the brain, detectable approximately 20 years prior to symptoms. The study suggests that novel therapies could prevent the onset of Alzheimer's by addressing mitochondrial impairment.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalTranslational Neuroscience·DateMar 28, 2011